Never self-modify your Ozempic regimen
The once-daily pill helps patients with obesity and type 2 diabetes lose weight and lower their blood sugar levels
Why titration matters more with triple agonists Retatrutide activates three receptor systems simultaneously
If you are on Wegovy or Zepbound for cardiovascular risk, obstructive sleep apnea, type 2 diabetes, or MASH, your medication is covered under standard Part D not the Bridge
If your genetic profile shows reduced GLP1R sensitivity, your appetite suppression might be less intense, meaning a different calorie target than someone with typical receptor function
Understanding Diabetic Acute Kidney Disease and the Role of GLP-1 RAs Diabetic kidney disease (DKD) is a common yet challenging complication of diabetes, often leading to chronic kidney damage, cardiovascular issues, and even end-stage renal disease (ESRD) if left untreated